The Discounted Cash Flow (DCF) valuation of Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS) is 5.32 CNY. With the latest stock price at 9.02 CNY, the upside of Zhejiang Cheng Yi Pharmaceutical Co Ltd based on DCF is -41.0%.
Based on the latest price of 9.02 CNY and our DCF valuation, Zhejiang Cheng Yi Pharmaceutical Co Ltd (603811.SS) is a sell. selling 603811.SS stocks now will result in a potential gain of 41.0%.
| Range | Selected | |
| WACC / Discount Rate | 9.4% - 11.4% | 10.4% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 4.25 - 7.18 | 5.32 |
| Upside | -52.9% - -20.4% | -41.0% |